Paul E. McGarry - Mar 17, 2023 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Signature
/s/ David Kull, Attorney-in-Fact for Paul E. McGarry
Stock symbol
RMTI
Transactions as of
Mar 17, 2023
Transactions value $
$0
Form type
4
Date filed
3/21/2023, 06:33 PM
Previous filing
Sep 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMTI Common Stock Award $0 +28.5K $0.00 28.5K Mar 17, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMTI Stock Option (Right to Buy) Award $0 +37.2K $0.00 37.2K Mar 17, 2023 Common Stock 37.2K $1.37 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") vest in two equal installments on the first and second anniversaries of March 17, 2023, subject to the Reporting Person's continued service to the Issuer. RSUs are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders.
F2 Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders.